TY - JOUR
T1 - Heparin-induced thrombocytopenia in patients with cerebrovascular ischemic disease
AU - Ramirez-Lassepas, Manuel
AU - Cipolle, Robert J.
AU - Rodvold, Keith A.
AU - Seifert, Randall D
AU - Strand, Linda
AU - Taddeini, Luigi
AU - Cusulos, Marsha
PY - 1984/6
Y1 - 1984/6
N2 - We studied 137 patients who were treated with heparin for cerebral infarction (73), partially reversible ischemic neurologic deficit (22), or transient ischemic attack (42). Platelet counts were performed before therapy, twice weekly, and at cessation of therapy. Platelets decreased in 118 patients (86%). In 21 (15.3%), platelets dropped ≥ 40%; 9 of 14 new ischemic events and three of six deaths occurred in this group of patients. Because there was a significant association between poor outcome and platelet drop ≥ 40% (p < 0.001), we believe that platelets should be monitored frequently when patients are treated with heparin for ischemic cerebrovascular disease.
AB - We studied 137 patients who were treated with heparin for cerebral infarction (73), partially reversible ischemic neurologic deficit (22), or transient ischemic attack (42). Platelet counts were performed before therapy, twice weekly, and at cessation of therapy. Platelets decreased in 118 patients (86%). In 21 (15.3%), platelets dropped ≥ 40%; 9 of 14 new ischemic events and three of six deaths occurred in this group of patients. Because there was a significant association between poor outcome and platelet drop ≥ 40% (p < 0.001), we believe that platelets should be monitored frequently when patients are treated with heparin for ischemic cerebrovascular disease.
UR - http://www.scopus.com/inward/record.url?scp=0021266043&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021266043&partnerID=8YFLogxK
U2 - 10.1212/wnl.34.6.736
DO - 10.1212/wnl.34.6.736
M3 - Article
C2 - 6539434
AN - SCOPUS:0021266043
SN - 0028-3878
VL - 34
SP - 736
EP - 740
JO - Neurology
JF - Neurology
IS - 6
ER -
